|
|
Blood, 15 January 2006, Vol. 107, No. 2, pp. 423-430.
Prepublished online as a Blood First Edition Paper on September 29, 2005; DOI 10.1182/blood-2005-04-1425.
Previous Article | Table of Contents | Next Article 
PLENARY PAPERS
C1qTNFrelated protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen
Gerald Lasser,
Prasenjit Guchhait,
Jeff L. Ellsworth,
Paul Sheppard,
Ken Lewis,
Paul Bishop,
Miguel A. Cruz,
Jose A. Lopez, and
Joachim Fruebis
From ZymoGenetics, Cardiovascular Biology, Seattle, WA; and Baylor College of Medicine, Houston, TX.
CTRP-1 is a novel member of the C1qTNFrelated protein family containing family characteristic collagen and TNF-like domains and shows marked expression in vascular wall tissue. We observed that recombinant human CTRP-1 specifically bound to fibrillar collagen and blocked collagen-induced platelet aggregation. CTRP-1 completely or partially prevented VWF and GPVI-Fc4 binding to collagen, respectively. However, GPVI-Fc4 failed to compete for the binding of CTRP-1 to collagen. CTRP-1 had no effects on 2 1 integrin Idomain binding to collagen. Using whole human blood under flow at low and high shear rates, CTRP-1 prevented platelets from accumulating on a collagen-coated surface but had no effects on "platelet-rolling" on a surface coated with VWF. These data suggest that CTRP-1 prevents collagen-induced platelet aggregation by specific blockade of VWF binding to collagen. By using the Folts vascular injury model in nonhuman primates (Macaca fascicularis), we were able to demonstrate that CTRP-1 can prevent platelet thrombosis in vivo. This effect was achieved in the absence of changes in activated-clotting time (ACT) and template cut bleeding times, suggesting that CTRP-1 has promising antiplatelet thrombotic activity and most likely acts by pacifying the thrombogenic site of vascular injury.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Platelet-collagen interaction: a new modulator
- Alastair W. Poole
Blood 2006 107: 415a-416.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. H. Jeon, K.-y. Kim, J. H. Kim, A. Baek, H. Cho, Y. H. Lee, J. W. Kim, D. Kim, S. H. Han, J.-S. Lim, et al.
A novel adipokine CTRP1 stimulates aldosterone production
FASEB J,
May 1, 2008;
22(5):
1502 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Calvo, F. Tokumasu, O. Marinotti, J.-L. Villeval, J. M. C. Ribeiro, and I. M. B. Francischetti
Aegyptin, a Novel Mosquito Salivary Gland Protein, Specifically Binds to Collagen and Prevents Its Interaction with Platelet Glycoprotein VI, Integrin {alpha}2beta1, and von Willebrand Factor
J. Biol. Chem.,
September 14, 2007;
282(37):
26928 - 26938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Meadows and D. L. Bhatt
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Circ. Res.,
May 11, 2007;
100(9):
1261 - 1275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lisman, N. Raynal, D. Groeneveld, B. Maddox, A. R. Peachey, E. G. Huizinga, P. G. de Groot, and R. W. Farndale
A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides
Blood,
December 1, 2006;
108(12):
3753 - 3756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cho and D. F. Mosher
Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor
Blood,
October 1, 2006;
108(7):
2229 - 2236.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|